FDA Drug recall D-0840-2020
Kushim Tablets (Gushim) 45-count packages, Label in foreign language
- FDA Drug
- Class II
- terminated
- Published 2020-02-19
On 2020-02-19 the FDA classified a Class II recall of Kushim Tablets (Gushim) 45-count packages, Label in foreign language by B And A Trading, citing marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0840-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-01-28 |
| Published | 2020-02-19 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | B And A Trading |
| Distribution | NJ, NY |
Product
Kushim Tablets (Gushim) 45-count packages, Label in foreign language
Reason
Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine
Identifiers
| code_info | Lot #: H003 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0840-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.